VIVA BIOTECH HOLDINGS revenue for the last year amounted to 2.37 B HKD, the most of which — 1.45 B HKD — came from its highest performing source at the moment, Contract Development Manufacture Organisation and Commercialisation, the year earlier bringing 1.73 B HKD. The greatest contribution to the revenue figure was made by United States — last year it brought VIVA BIOTECH HOLDINGS 898.13 M HKD, and the year before that — 1.06 B HKD.